Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Smoking Cessation
Condition: Quit smoking date regimen (Days 1-3)
Dose: Oral – 0.5 mg
Frequency: once daily
Note: Initiate regimen 1 week before quit smoking date. Alternatively, the patient can begin varenicline and then quit smoking between days 8 and 35 of treatment.
Indication: Smoking Cessation
Condition: Quit smoking date regimen (Days 4-7)
Dose: Oral – 0.5 mg
Frequency: twice daily
Note: Initiate regimen 1 week before quit smoking date. Alternatively, the patient can begin varenicline and then quit smoking between days 8 and 35 of treatment.

Child Dose

Clinical InformationAdministration Information
Age: less than 18 years
Dose: Not established
Note: Safety and efficacy not established

Renal Dose

Clinical InformationAdministration Information
Condition: Mild-to-moderate renal impairment (creatinine clearance greater than or equal to 30 mL/min)
Dose: Dose:
Note: No dosage adjustment required
Condition: Renal impairment Severe (CrCl < 30 mL/min)
Dose: Oral - 0.5 mg once daily initially
Note: May increase to Oral - 0.5 mg every 12 hours
Administration
  • Take after eating
  • Take with full glass of water
Side Effect

Drug Interaction

Drug NameRisk Factors
Transdermal nicotine
Increased incidence of adverse effects (nausea, vomiting)
Cimetidine
Increased exposure

Disease Interaction

Disease NameRisk Factors
Non-smokers
Not indicated for non-smokers

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.